Adrenocortical Carcinoma Steroid Profiles: In Silico Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved Outcomes

Despite progress in understanding the biology of adrenocortical carcinoma (ACC), treatment options have not dramatically changed in the last three decades, nor have we learned how to avoid some of its long-term side effects. Our goal was to improve the understanding of immune pathways that may inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzzi, João C. D., Magno, Jessica M., Cardoso, Milena A., de Moura, Juliana, Castro, Mauro A. A., Figueiredo, Bonald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237859/
https://www.ncbi.nlm.nih.gov/pubmed/34194394
http://dx.doi.org/10.3389/fendo.2021.672319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237859/
https://www.ncbi.nlm.nih.gov/pubmed/34194394
http://dx.doi.org/10.3389/fendo.2021.672319

Ejemplares similares